share_log

西藏药业(600211.SH):公司继续在高原药材种植基地开展红景天人工栽培研究

Tibet Pharmaceutical (600211.SH): The company continues to carry out research on artificial cultivation of rhodiola rosea at the plateau medicinal herb cultivation base

Gelonghui Finance ·  Dec 7, 2023 04:49

On December 7, Gelonghui, Tibet Pharmaceutical (600211.SH) said at the performance briefing that the company continues to carry out research on artificial cultivation of rhodiola at the plateau medicinal herb planting site, and is currently conducting cultivation observations on various rhodiola resources, and is currently conducting research on rhodiola hydroponics technology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment